Stopping GLP-1 drugs like Ozempic quickly erodes heart protection, with two years off the medication raising cardiovascular ...

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

A recent research revealed that discontinuing GLP-1 drugs for diabetes may increase the risk of cardiac events, stroke, and ...

The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, ...

Tirzepatide is linked to lower cardiovascular risk than dulaglutide for adults with type 2 diabetes and atherosclerotic ...

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in ...

Yunmeng Liu, Ph.D., an assistant professor in the College of Medicine Department of Pharmacology and Toxicology at the ...

March 20 () - Taking GLP-1 drugs for diabetes has been shown to lower the risk of adverse heart events, but a new analysis ...

At the recent American Association of Clinical Endocrinology (AACE) annual meeting, experts highlighted new approaches to identifying and managing hypercortisolism in patients with type 2 diabetes, ...

Making thoughtful protein choices is an important part of managing diabetes, as these decisions not only affect blood sugar levels but also contribute to overall health, especially heart health—a ...

When oral care is neglected, harmful bacteria can multiply and lead to infections and systemic diseases.